Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by davewhoon Apr 07, 2021 8:15pm
154 Views
Post# 32954489

RE:RE:RE:RE:StageZero Twitter - FAQ on the Acquisition

RE:RE:RE:RE:StageZero Twitter - FAQ on the AcquisitionI'm beginning to understand the strategy. James could not care less about the SP they are cashed upped, have steady Covid19 money coming in and have a long term plan to save millions of lives. The deal is not SP connected. The more Aristotle tests Care Oncology sells the more rev szls makes, the more the sp rises and the more the shares held by Care Oncology are worth. Its a growth driven plan. Everyone wins if the tests sell. Brilliant plan if they can make it work. Care has the contacts and MUST be a believer in Aristotle since they have put their company on the line. Care could go from having 2 clinics to having a clinic in every state. Plus Europe and Canada. Makes you wonder where this goes? Won't happen over nite for sure but the possibilities are pretty compelling. IMO
<< Previous
Bullboard Posts
Next >>